Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

By | June 18, 2021
A new study, released as a preprint on bioRxiv* server, shows that a combination of the biological interferon-α and the small molecule nafamostat are effective against SARS-CoV-2 infection in vitro, as well as in vivo.